Publicaciones en las que colabora con Juan José Corrales Hernández (14)

2014

  1. Research update for articles published in EJCI in 2012

    European Journal of Clinical Investigation, Vol. 44, Núm. 10, pp. 1010-1023

  2. Testosterone replacement therapy in hypogonadal men is associated with increased expression of LAMP-2 (CD107b) by circulating monocytes and dendritic cells

    Clinical Endocrinology, Vol. 80, Núm. 4, pp. 577-584

2012

  1. Enhanced immunological response by dendritic cells in male hypogonadism

    European Journal of Clinical Investigation, Vol. 42, Núm. 11, pp. 1205-1212

2009

  1. Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency

    Fertility and Sterility, Vol. 92, Núm. 1, pp. 311-319

2007

  1. Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications

    Journal of Diabetes and its Complications, Vol. 21, Núm. 1, pp. 41-49

2006

  1. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men and partial androgen deficiency

    Journal of Endocrinology, Vol. 189, Núm. 3, pp. 595-604

2004

  1. Partial Androgen Deficiency in Aging Type 2 Diabetic Men and Its Relationship to Glycemic Control

    Metabolism: Clinical and Experimental, Vol. 53, Núm. 5, pp. 666-672

2001

  1. The distribution of the major peripheral blood T, B and NK cell subsets does not predict the clinical outcome of Graves' disease patients after methimazole therapy

    Journal of Biological Regulators and Homeostatic Agents, Vol. 14, Núm. 3, pp. 193-199

1997

  1. Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves disease: Relationship with disease activity

    Communications in Clinical Cytometry, Vol. 30, Núm. 3, pp. 118-123

  2. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells

    Journal of Endocrinology, Vol. 155, Núm. 3, pp. 491-500

1996

  1. CD5+ B cells in Graves' disease: Correlation with disease activity

    Hormone and Metabolic Research, Vol. 28, Núm. 6, pp. 280-285

  2. Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves' disease

    Journal of Endocrinology, Vol. 151, Núm. 2, pp. 231-240

1994

  1. The relationships between hyperthyroidism and the distribution of peripheral blood T, NK and B-lymphocytes in multinodular goiter

    Hormone and Metabolic Research, Vol. 26, Núm. 2, pp. 104-108

1993

  1. Immunological features of sporadic multinodular goiter

    The Clinical Investigator, Vol. 71, Núm. 7, pp. 552-558